Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadobutrol for CNS MRI in Japanese Subjects
NCT01660841Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadobutrol in Central nervous system lesion, sponsored by Bayer. Started Sep 2012; status: completed.
02
Drugs
gadobutrol
03
Conditions
Central nervous system lesion
Beyond the preview
Go deeper on NCT01660841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01660841.